Insider Trading Activity Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) – CEO Bought 1,695 shares of Stock

ME Staff
-
0

Insider Trading Activity For Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)

Yuval Cohen , CEO of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) reportedly Bought 1,695 shares of the company’s stock at an average price of 6 for a total transaction amount of $10,170.00 SEC Form

Insider Trading History For Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)

  • On 11/25/2014 Sean F Moran, CFO, bought 3,000 with an average share price of $3.05 per share and the total transaction amounting to $9,150.00.View SEC Filing
  • On 11/25/2014 Mark Tepper, Insider, bought 2,000 with an average share price of $3.05 per share and the total transaction amounting to $6,100.00.View SEC Filing
  • On 11/26/2014 Sean F Moran, CFO, bought 1,000 with an average share price of $3.05 per share and the total transaction amounting to $3,050.00.View SEC Filing
  • On 11/26/2014 Barbara White, Insider, bought 13,400 with an average share price of $3.00 per share and the total transaction amounting to $40,200.00.View SEC Filing
  • On 11/28/2014 Barbara White, Insider, bought 19,933 with an average share price of $3.00 per share and the total transaction amounting to $59,799.00.View SEC Filing
  • On 12/1/2014 Barbara White, Insider, bought 16,448 with an average share price of $3.00 per share and the total transaction amounting to $49,344.00.View SEC Filing
  • On 12/2/2014 Sean F Moran, CFO, bought 1,000 with an average share price of $3.03 per share and the total transaction amounting to $3,030.00.View SEC Filing

    • Analyst Ratings For Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)
    These are 4 Buy Ratings .
    The current consensus rating for Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is Buy (Score: 3.00) with a consensus target price of $20.50 , a potential (229.32% upside)

    Analyst Ratings History For Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)

    • On 11/30/2016 Aegis Reiterated Rating Buy with a price target of $12.00
    • On 4/3/2017 JMP Securities Reiterated Rating Outperform with a price target of $20.00 to $27.00
    • On 8/9/2017 Noble Financial Reiterated Rating Buy
    • On 8/9/2017 Cantor Fitzgerald Set Price Target of rating Buy with a price target of $24.00

    Recent Trading Activity for Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)
    Shares of Corbus Pharmaceuticals Holdings, Inc. closed the previous trading session at 6.22 up +0.38 6.41% with 340,113 shares trading hands.